Portfolio company
Longitude Prize on ALS
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The organisation provides an international challenge programme and datasets to incentivise researchers to discover and validate therapeutic targets for motor neurone disease using artificial intelligence.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Motor Neuron Disease Association
This charity provides support services, equipment loans and research funding for people affected by motor neurone disease in England, Wales and Northern Ireland.
Verge Genomics
This company develops neurodegenerative disease treatments for pharmaceutical partners and patients using an artificial intelligence platform trained on proprietary human genomic datasets.
PharmEnable
This company develops small molecule medicines using an artificial intelligence platform for pharmaceutical partners and patients with oncology and neurology conditions.
Trace Neuroscience
This biopharmaceutical company develops genomic therapies to restore protein function and nerve communication for patients with amyotrophic lateral sclerosis and neurodegenerative diseases.
Biorelate
This company develops an artificial intelligence platform that curates biomedical data to support drug discovery for pharmaceutical and life sciences organisations.
Gain Therapeutics
This biotechnology company develops allosteric small molecule therapies for patients with neurodegenerative diseases and rare genetic disorders using an artificial intelligence drug discovery platform.
Relation Therapeutics
This biotechnology firm develops an artificial intelligence platform to identify and validate therapeutic drug targets for pharmaceutical companies and research partners.
Yield Guild Games
This organisation provides a platform and digital assets for blockchain gamers to participate in play-to-earn economies and train artificial intelligence models.
